122 related articles for article (PubMed ID: 33045189)
1. Steroids for sepsis and ARDS: this eternal controversy remains with COVID-19.
Carlet J; Payen D; Opal SM
Lancet; 2020 Oct; 396(10259):e61-e62. PubMed ID: 33045189
[No Abstract] [Full Text] [Related]
2. Mesenchymal stromal cells for acute respiratory distress syndrome (ARDS), sepsis, and COVID-19 infection: optimizing the therapeutic potential.
Gorman E; Millar J; McAuley D; O'Kane C
Expert Rev Respir Med; 2021 Mar; 15(3):301-324. PubMed ID: 33172313
[No Abstract] [Full Text] [Related]
3. COVID-19 and non-COVID ARDS patients demonstrate a distinct response to low dose steroids- A retrospective observational study.
Longobardo A; Snow TAC; Montanari C; Shulman R; Singer M; Arulkumaran N
J Crit Care; 2021 Apr; 62():46-48. PubMed ID: 33260010
[TBL] [Abstract][Full Text] [Related]
4. Treating hypoxemic COVID-19 "ARDS" patients with almitrine: The earlier the better?
Bendjelid K; Giraud R; Von Düring S
Anaesth Crit Care Pain Med; 2020 Aug; 39(4):451-452. PubMed ID: 32653550
[No Abstract] [Full Text] [Related]
5. Metformin in acute respiratory distress syndrome: An opinion.
Uddin MA; Akhter MS; Kubra KT; Siejka A; Barabutis N
Exp Gerontol; 2021 Mar; 145():111197. PubMed ID: 33310152
[TBL] [Abstract][Full Text] [Related]
6. Dapsone, colchicine and olanzapine as treatment adjuncts to prevent COVID-19 associated adult respiratory distress syndrome (ARDS).
Altschuler EL; Kast RE
Med Hypotheses; 2020 Aug; 141():109774. PubMed ID: 32344275
[No Abstract] [Full Text] [Related]
7. Respiratory characteristics and related intraoperative ventilatory management for patients with COVID-19 pneumonia.
Aoyama H; Uchida K
J Anesth; 2021 Jun; 35(3):356-360. PubMed ID: 32865700
[TBL] [Abstract][Full Text] [Related]
8. Potential for personalised application of inhaled nitric oxide in COVID-19 pneumonia.
Garfield B; McFadyen C; Briar C; Bleakley C; Vlachou A; Baldwin M; Lees N; Price S; Ledot S; McCabe C; Wort SJ; Patel BV; Price LC
Br J Anaesth; 2021 Feb; 126(2):e72-e75. PubMed ID: 33288208
[No Abstract] [Full Text] [Related]
9. Using the lung ultrasound score to monitor disease progression for COVID-19-associated ARDS.
Nguyen M; Gaujard G; Guinot PG; Bouhemad B;
Intensive Care Med; 2021 Nov; 47(11):1329-1331. PubMed ID: 34595567
[No Abstract] [Full Text] [Related]
10. Δ9-Tetrahydrocannabinol Prevents Mortality from Acute Respiratory Distress Syndrome through the Induction of Apoptosis in Immune Cells, Leading to Cytokine Storm Suppression.
Mohammed A; F K Alghetaa H; Miranda K; Wilson K; P Singh N; Cai G; Putluri N; Nagarkatti P; Nagarkatti M
Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32872332
[TBL] [Abstract][Full Text] [Related]
11. Efficacy and safety of corticosteroids in COVID-19 based on evidence for COVID-19, other coronavirus infections, influenza, community-acquired pneumonia and acute respiratory distress syndrome: a systematic review and meta-analysis.
Ye Z; Wang Y; Colunga-Lozano LE; Prasad M; Tangamornsuksan W; Rochwerg B; Yao L; Motaghi S; Couban RJ; Ghadimi M; Bala MM; Gomaa H; Fang F; Xiao Y; Guyatt GH
CMAJ; 2020 Jul; 192(27):E756-E767. PubMed ID: 32409522
[TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 antibody immunoassays in serial samples reveal earlier seroconversion in acutely ill COVID-19 patients developing ARDS.
Buchholtz ML; Arend FM; Eichhorn P; Weigand M; Kleinhempel A; Häusler K; Bruegel M; Holdt LM; Teupser D
PLoS One; 2021; 16(5):e0251587. PubMed ID: 33984048
[TBL] [Abstract][Full Text] [Related]
13. Recombinant tissue plasminogen activator treatment for COVID-19 associated ARDS and acute cor pulmonale.
Kosanovic D; Yaroshetskiy AI; Tsareva NA; Merzhoeva ZM; Trushenko NV; Nekludova GV; Schermuly RT; Avdeev SN
Int J Infect Dis; 2021 Mar; 104():108-110. PubMed ID: 33352323
[TBL] [Abstract][Full Text] [Related]
14. Steroids in ARDS: more light is being shed.
Arulkumaran N; Snow TAC; Longobardo A; Brealey D; Singer M
Intensive Care Med; 2020 Nov; 46(11):2108-2110. PubMed ID: 32886206
[No Abstract] [Full Text] [Related]
15. [Inflammation during COVID-19].
Misset B; Parzibut G; Layios N; Cavalleri J; Delvenne P; Desmecht D; Rousseau AF; Lambermont B
Rev Med Liege; 2022 May; 77(5-6):277-284. PubMed ID: 35657183
[TBL] [Abstract][Full Text] [Related]
16. P-selectin blockade in COVID-19-related ARDS.
Neri T; Nieri D; Celi A
Am J Physiol Lung Cell Mol Physiol; 2020 Jun; 318(6):L1237-L1238. PubMed ID: 32464083
[No Abstract] [Full Text] [Related]
17. Vitamin D receptor stimulation to reduce acute respiratory distress syndrome (ARDS) in patients with coronavirus SARS-CoV-2 infections: Revised Ms SBMB 2020_166.
Quesada-Gomez JM; Entrenas-Castillo M; Bouillon R
J Steroid Biochem Mol Biol; 2020 Sep; 202():105719. PubMed ID: 32535032
[TBL] [Abstract][Full Text] [Related]
18. SARS-CoV-2-Induced ARDS Associates with MDSC Expansion, Lymphocyte Dysfunction, and Arginine Shortage.
Reizine F; Lesouhaitier M; Gregoire M; Pinceaux K; Gacouin A; Maamar A; Painvin B; Camus C; Le Tulzo Y; Tattevin P; Revest M; Le Bot A; Ballerie A; Cador-Rousseau B; Lederlin M; Lebouvier T; Launey Y; Latour M; Verdy C; Rossille D; Le Gallou S; Dulong J; Moreau C; Bendavid C; Roussel M; Cogne M; Tarte K; Tadié JM
J Clin Immunol; 2021 Apr; 41(3):515-525. PubMed ID: 33387156
[TBL] [Abstract][Full Text] [Related]
19. Intravenous immunoglobulin therapy for COVID-19 ARDS.
Wilfong EM; Matthay MA
Lancet Respir Med; 2022 Feb; 10(2):123-125. PubMed ID: 34774186
[No Abstract] [Full Text] [Related]
20. Effects of inhaled nitric oxide in COVID-19-induced ARDS-Is it worthwhile?
Kobayashi J
Acta Anaesthesiol Scand; 2021 Nov; 65(10):1522-1523. PubMed ID: 34309854
[No Abstract] [Full Text] [Related]
[Next] [New Search]
